Nottingham University Hospital
Nottingham NG7 2UH
3 studies enrolling now · 24 studies all time
What they study most
Acute Alcoholic Hepatitis, Acute Ischemic Stroke, Acute Kidney Injury, Acute Major Bleeding, Ankylosing Spondylitis, Breast Cancer, COVID-19, Carotid Stenosis, Chronic Cough, Colorectal Cancer, Enterocutaneous Fistula, Esophageal Adenocarcinoma
Studies at this site
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread — Recruiting now
- Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
- Exactech Shoulder Post Market Clinical Follow-up Study — Recruiting now
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
- Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor — Stopped early
- Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma — Running, not enrolling
- Chyme Reinfusion for Type 2 Intestinal Failure — Completed
- Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients — Status unconfirmed
- Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial) — Completed
- EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
- A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage — Completed
- Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 — Completed
- Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
- Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer — Running, not enrolling
- A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF — Stopped early
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy — Completed
- Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD — Stopped early
- A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
- Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed
- Splenic Injury Embolization - the Question About NOM (SInE Qua NOM) — Status unconfirmed
- A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) — Completed
- BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection — Status unconfirmed
- A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer — Completed
- Ulimorelin Study of Efficacy and Safety (ULISES 007) — Completed